Symbols / MIRA Stock $0.99 -1.30% MIRA Pharmaceuticals, Inc.
MIRA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Ratings
Current target
$0.99
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-09-30 | init | Rodman & Renshaw | — → Buy | $17 |
| 2024-08-05 | init | Ascendiant Capital | — → Buy | $11 |
- What's going on with MIRA Pharma stock Tuesday? - MSN Wed, 06 May 2026 12
- MIRA Pharmaceuticals (MIRA) CEO granted 83,500 RSUs - Stock Titan Wed, 01 Apr 2026 07
- Should I buy MIRA Pharmaceuticals (MIRA) stock right now | Q3 2025: EPS Exceeds Expectations - Margin of Safety - UBND thành phố Hải Phòng hu, 23 Apr 2026 01
- Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making - Stocktwits hu, 05 Mar 2026 08
- MIRA Pharmaceuticals (MIRA) Top Loser | Q3 2025: Profit Surprises - P/B Ratio - Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 23
- Indiana tech judges give Syra Health 2 Mira Awards for health tools - Stock Titan ue, 28 Apr 2026 07
- MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55 - TipRanks Mon, 23 Mar 2026 07
- Mira Rajput meets MIL Supriya Pathak for coffee, Sana Kapur shares 'proof of whom mom loves more' - The Times of India Mon, 23 Feb 2026 08
- MIRA pain drug showed morphine-like relief without THC-like effects - Stock Titan Mon, 23 Mar 2026 13
- MIRA Pharmaceuticals (MIRA) Stock: Momentum Analysis (Momentum Building) 2026-04-16 - Low Volatility Stocks - Xã Vĩnh Công hu, 16 Apr 2026 08
- Nvidia Stock (NVDA) Climbs on Multi-Year AI Deal with Mira Murati’s Thinking Machines Lab - TipRanks ue, 10 Mar 2026 07
- Is SFL Corporation (SFL) Stock a Safe Investment | Price at $10.95, Up 0.18% - Weak Sell Rating - Cổng thông tin điện tử tỉnh Lào Cai Mon, 06 Apr 2026 07
- Mira Rajput revives childhood through 'Panchatantra'; Shares adorable night routine - The Times of India Fri, 20 Feb 2026 08
- MIRA Stock Analysis: MIRA Pharmaceuticals Inc. rises 4.72 pct to hold 1.11 level - Xã Thanh Hà Fri, 03 Apr 2026 07
- Ketamir-2 trial progress and pipeline update at MIRA (NASDAQ: MIRA) - Stock Titan Mon, 02 Feb 2026 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
10.49
+30.86%
|
8.02
-5.95%
|
8.53
+20.97%
|
7.05
|
| Research And Development |
|
1.72
-47.97%
|
3.31
+110.15%
|
1.57
-33.11%
|
2.35
|
| Selling General And Administration |
|
8.77
+86.16%
|
4.71
-27.49%
|
6.50
+117.22%
|
2.99
|
| General And Administrative Expense |
|
8.77
+86.16%
|
4.71
-27.49%
|
6.50
+117.22%
|
2.99
|
| Other Gand A |
|
8.77
+86.16%
|
4.71
-27.49%
|
6.50
+117.22%
|
2.99
|
| Other Operating Expenses |
|
—
|
—
|
0.45
-73.39%
|
1.70
|
| Total Expenses |
|
10.49
+30.86%
|
8.02
-5.95%
|
8.53
+20.97%
|
7.05
|
| Operating Income |
|
-10.49
-30.86%
|
-8.02
+5.95%
|
-8.53
-20.97%
|
-7.05
|
| EBITDA |
|
-10.49
-30.86%
|
-8.02
+5.95%
|
-8.53
-20.97%
|
-7.05
|
| Normalized EBITDA |
|
-10.46
-30.42%
|
-8.02
+5.95%
|
-8.53
-20.97%
|
-7.05
|
| EBIT |
|
-10.49
-30.86%
|
-8.02
+5.95%
|
-8.53
-20.97%
|
-7.05
|
| Total Unusual Items |
|
-0.04
|
—
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.04
|
—
|
—
|
—
|
| Net Income |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Pretax Income |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Net Non Operating Interest Income Expense |
|
0.10
-40.30%
|
0.17
+104.79%
|
-3.46
-33619.94%
|
-0.01
|
| Interest Expense Non Operating |
|
—
|
—
|
3.46
+33619.94%
|
0.01
|
| Net Interest Income |
|
0.10
-40.30%
|
0.17
+104.79%
|
-3.46
-33619.94%
|
-0.01
|
| Interest Expense |
|
—
|
—
|
3.46
+33619.94%
|
0.01
|
| Interest Income Non Operating |
|
0.10
-40.30%
|
0.17
|
—
|
—
|
| Interest Income |
|
0.10
-40.30%
|
0.17
|
—
|
—
|
| Other Income Expense |
|
-0.05
|
—
|
—
|
—
|
| Other Non Operating Income Expenses |
|
-0.01
|
—
|
—
|
—
|
| Gain On Sale Of Security |
|
-0.04
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Net Income From Continuing Operation Net Minority Interest |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Net Income From Continuing And Discontinued Operation |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Net Income Continuous Operations |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Normalized Income |
|
-10.41
-32.53%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Net Income Common Stockholders |
|
-32.00
-307.50%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Otherunder Preferred Stock Dividend |
|
21.56
|
0.00
|
—
|
—
|
| Diluted EPS |
|
-1.35
-164.71%
|
-0.51
+40.00%
|
-0.85
-113.77%
|
-0.40
|
| Basic EPS |
|
-1.35
-164.71%
|
-0.51
+40.00%
|
-0.85
-113.77%
|
-0.40
|
| Basic Average Shares |
|
23.69
+53.42%
|
15.44
+10.91%
|
13.92
-21.55%
|
17.75
|
| Diluted Average Shares |
|
23.69
+53.42%
|
15.44
+10.91%
|
13.92
-21.55%
|
17.75
|
| Diluted NI Availto Com Stockholders |
|
-32.00
-307.50%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Total Other Finance Cost |
|
—
|
-0.17
-104.79%
|
3.46
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
11.09
+279.52%
|
2.92
-40.74%
|
4.93
+474.83%
|
0.86
|
| Current Assets |
|
11.06
+282.95%
|
2.89
-40.56%
|
4.86
+882.64%
|
0.49
|
| Cash Cash Equivalents And Short Term Investments |
|
11.03
+289.35%
|
2.83
-38.45%
|
4.60
+1211.35%
|
0.35
|
| Cash And Cash Equivalents |
|
6.35
+124.04%
|
2.83
-38.45%
|
4.60
+1211.35%
|
0.35
|
| Cash Financial |
|
6.35
+124.04%
|
2.83
-38.45%
|
4.60
+1211.35%
|
0.35
|
| Other Short Term Investments |
|
4.68
|
0.00
|
—
|
—
|
| Receivables |
|
—
|
0.00
-100.00%
|
0.01
|
0.00
|
| Other Receivables |
|
—
|
—
|
0.01
|
—
|
| Prepaid Assets |
|
0.03
-48.57%
|
0.05
-77.55%
|
0.24
|
0.00
|
| Current Deferred Assets |
|
—
|
—
|
0.00
-100.00%
|
0.14
|
| Total Non Current Assets |
|
0.04
+0.00%
|
0.04
-52.25%
|
0.07
-79.59%
|
0.36
|
| Net PPE |
|
—
|
0.00
-100.00%
|
0.01
-98.61%
|
0.36
|
| Gross PPE |
|
—
|
0.00
-100.00%
|
0.01
-98.61%
|
0.36
|
| Other Properties |
|
—
|
—
|
0.01
-98.61%
|
0.36
|
| Non Current Accounts Receivable |
|
0.04
+0.00%
|
0.04
-48.75%
|
0.07
|
—
|
| Non Current Prepaid Assets |
|
—
|
—
|
—
|
0.00
|
| Total Liabilities Net Minority Interest |
|
0.70
-2.94%
|
0.72
+29.61%
|
0.56
-61.62%
|
1.45
|
| Current Liabilities |
|
0.70
-2.94%
|
0.72
+29.61%
|
0.56
-59.26%
|
1.37
|
| Payables And Accrued Expenses |
|
0.70
-2.94%
|
0.72
+30.80%
|
0.55
-42.58%
|
0.96
|
| Payables |
|
0.70
-2.94%
|
0.72
+34.31%
|
0.54
-40.53%
|
0.91
|
| Accounts Payable |
|
0.13
-82.14%
|
0.72
+34.31%
|
0.54
-31.76%
|
0.79
|
| Current Accrued Expenses |
|
—
|
0.00
-100.00%
|
0.01
-74.84%
|
0.06
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
0.01
-98.76%
|
0.41
|
| Current Debt |
|
—
|
—
|
—
|
0.13
|
| Current Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
0.01
-98.15%
|
0.27
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.08
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
0.08
|
| Long Term Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
0.08
|
| Stockholders Equity |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+833.67%
|
-0.60
|
| Common Stock Equity |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+833.67%
|
-0.60
|
| Capital Stock |
|
0.00
+153.26%
|
0.00
+12.04%
|
0.00
-77.80%
|
0.01
|
| Common Stock |
|
0.00
+153.26%
|
0.00
+12.04%
|
0.00
-77.80%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
41.94
+153.24%
|
16.56
+12.04%
|
14.78
+0.24%
|
14.75
|
| Ordinary Shares Number |
|
41.94
+153.24%
|
16.56
+12.04%
|
14.78
+0.24%
|
14.75
|
| Additional Paid In Capital |
|
49.97
+59.46%
|
31.34
+22.13%
|
25.66
+194.92%
|
8.70
|
| Retained Earnings |
|
-39.58
-35.84%
|
-29.14
-36.89%
|
-21.29
-128.80%
|
-9.30
|
| Total Equity Gross Minority Interest |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+833.67%
|
-0.60
|
| Total Capitalization |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+833.67%
|
-0.60
|
| Working Capital |
|
10.36
+378.49%
|
2.16
-49.67%
|
4.30
+591.09%
|
-0.88
|
| Invested Capital |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+1044.44%
|
-0.46
|
| Total Debt |
|
—
|
0.00
-100.00%
|
0.01
-98.97%
|
0.49
|
| Capital Lease Obligations |
|
—
|
0.00
-100.00%
|
0.01
-98.59%
|
0.36
|
| Net Tangible Assets |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+833.67%
|
-0.60
|
| Tangible Book Value |
|
10.39
+372.40%
|
2.20
-49.71%
|
4.37
+833.67%
|
-0.60
|
| Duefrom Related Parties Non Current |
|
0.04
+0.00%
|
0.04
-48.75%
|
0.07
|
0.00
|
| Dueto Related Parties Current |
|
0.57
|
0.00
|
0.00
-100.00%
|
0.12
|
| Interest Payable |
|
—
|
0.00
-100.00%
|
0.01
-58.64%
|
0.03
|
| Line Of Credit |
|
—
|
—
|
0.00
-100.00%
|
0.13
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.66
+16.17%
|
-5.56
-22.69%
|
-4.53
+19.13%
|
-5.60
|
| Cash Flow From Continuing Operating Activities |
|
-4.66
+16.17%
|
-5.56
-22.69%
|
-4.53
+19.13%
|
-5.60
|
| Net Income From Continuing Operations |
|
-10.44
-32.98%
|
-7.85
+34.46%
|
-11.98
-69.77%
|
-7.06
|
| Other Non Cash Items |
|
—
|
—
|
5.54
+53935.92%
|
0.01
|
| Stock Based Compensation |
|
6.31
+228.67%
|
1.92
-24.70%
|
2.55
+96.74%
|
1.30
|
| Unrealized Gain Loss On Investment Securities |
|
0.04
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-0.57
-252.88%
|
0.37
+158.04%
|
-0.64
-536.41%
|
0.15
|
| Change In Receivables |
|
0.00
-100.00%
|
0.01
+200.00%
|
-0.01
|
0.00
|
| Changes In Account Receivables |
|
—
|
0.01
+200.00%
|
-0.01
|
0.00
|
| Change In Prepaid Assets |
|
0.03
-85.94%
|
0.19
+177.55%
|
-0.24
|
0.00
|
| Change In Payables And Accrued Expense |
|
-0.59
-448.86%
|
0.17
+143.72%
|
-0.39
-356.13%
|
0.15
|
| Change In Accrued Expense |
|
0.00
+100.00%
|
-0.01
|
0.00
|
—
|
| Change In Payable |
|
-0.59
-421.53%
|
0.18
+147.44%
|
-0.39
|
—
|
| Change In Account Payable |
|
-0.59
-421.53%
|
0.18
+147.44%
|
-0.39
|
—
|
| Change In Other Current Assets |
|
—
|
0.00
-100.00%
|
0.01
+200.00%
|
-0.01
|
| Change In Other Current Liabilities |
|
—
|
—
|
1.10
|
0.00
|
| Financing Cash Flow |
|
8.18
+115.66%
|
3.79
-56.84%
|
8.78
+179.19%
|
3.15
|
| Cash Flow From Continuing Financing Activities |
|
8.18
+115.66%
|
3.79
-56.84%
|
8.78
+179.19%
|
3.15
|
| Net Issuance Payments Of Debt |
|
0.57
|
0.00
-100.00%
|
1.01
+728.40%
|
-0.16
|
| Issuance Of Debt |
|
0.57
|
0.00
-100.00%
|
2.15
|
0.00
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-1.14
-614.05%
|
-0.16
|
| Long Term Debt Issuance |
|
0.57
|
0.00
|
—
|
—
|
| Net Long Term Debt Issuance |
|
0.57
|
0.00
|
—
|
—
|
| Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
2.15
|
0.00
|
| Short Term Debt Payments |
|
—
|
0.00
+100.00%
|
-1.14
-614.05%
|
-0.16
|
| Net Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
1.01
+728.40%
|
-0.16
|
| Net Common Stock Issuance |
|
7.01
+94.18%
|
3.61
-53.16%
|
7.70
+165.30%
|
2.90
|
| Proceeds From Stock Option Exercised |
|
0.89
|
0.00
|
—
|
—
|
| Net Other Financing Charges |
|
-0.29
-260.33%
|
0.18
+145.60%
|
0.07
-81.53%
|
0.40
|
| Changes In Cash |
|
3.51
+298.57%
|
-1.77
-141.62%
|
4.25
+272.93%
|
-2.46
|
| Beginning Cash Position |
|
2.83
-38.45%
|
4.60
+1211.35%
|
0.35
-87.51%
|
2.81
|
| End Cash Position |
|
6.35
+124.04%
|
2.83
-38.45%
|
4.60
+1211.35%
|
0.35
|
| Free Cash Flow |
|
-4.66
+16.17%
|
-5.56
-22.69%
|
-4.53
+19.13%
|
-5.60
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
—
|
| Change In Interest Payable |
|
0.00
+100.00%
|
-0.01
|
0.00
|
—
|
| Common Stock Issuance |
|
7.01
+94.18%
|
3.61
-53.16%
|
7.70
+165.30%
|
2.90
|
| Issuance Of Capital Stock |
|
7.01
+94.18%
|
3.61
-53.16%
|
7.70
+165.30%
|
2.90
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-01 View
- 10-K2026-03-31 View
- 8-K2026-03-23 View
- 8-K2026-03-03 View
- 8-K2026-02-02 View
- 8-K2025-12-22 View
- 8-K2025-12-05 View
- 10-Q2025-11-13 View
- 8-K2025-10-23 View
- 8-K2025-10-16 View
- 8-K2025-10-15 View
- 42025-10-03 View
- 42025-10-03 View
- 8-K2025-09-30 View
- 8-K2025-09-22 View
- 42025-09-18 View
- 8-K2025-09-15 View
- 8-K2025-09-11 View
- 42025-09-03 View
- 8-K2025-08-19 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|